Informa Markets will manage the massive health technology conference, while HIMSS will continue overseeing content and programming.
The organizations will evaluate the potential of generative AI and cloud technology to improve healthcare.
The partners are releasing a mobile app containing a digital version of the drug guide, the Lippincott Nursing Drug Handbook, complete with FDA updates.
The company utilizes machine learning and patient data to deliver personalized medication management pertaining to polypharmacy.
The purchase comes on the heels of the surgical navigation platform's $82.5 million Series D raise in June.
The Frontier Model Forum will identify best practices for responsible AI development, including supporting the creation of applications geared toward early cancer detection.
It expects continued long-term growth in the demand for virtual care services post-pandemic.
Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.
The company will use the investment to fuel the expansion of its FDA-cleared, AI-enabled surgical navigation platform, Paradigm.
